Please login to the form below

Not currently logged in
Email:
Password:

Razorfish Healthware forms mHealth partnership with app software firm

Teams up with Stamplay
image001-5

Razorfish Healthware agency has formed a strategic partnership with London-based Stamplay to create a customised healthcare version of its app software.

Publicis agency Razorfish said the collaboration would allow it to “optimise the app creation process for both pharmaceutical companies and healthcare providers”.

Roberto Ascione, president of Razorfish Healthcare, said: “The attention of the healthcare industry towards mHealth is palpable and there is no doubt this will be an area that will see a massive growth in the coming years.”

He added that working with Stamplay - which allows developers to streamline the creation of client-server web and mobile apps - would also allow the agency to offer a viable framework to health tech start ups.

Nicola Mattina, co-founder of Stamplay, added: “We are envisioning a version of our platform to enable large organisations in the healthcare industry to accelerate the testing and implementation of web and mobile applications that will be used by patients and doctors to for more effective prevention, improve disease management and adherence to treatment, and so on.”

mHealth continues to develop and mature, particularly in the consumer sector where, most recently, Apple launched its own HealthKit developer tools to drive the next stage of its mobile health technology.

Article by
Kirstie Pickering

25th September 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics